These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 982514)

  • 1. Evaluation of a mass measles immunization campaign in Yaoundé, Cameroun.
    McBean AM; Foster SO; Herrmann KL; Gateff C
    Trans R Soc Trop Med Hyg; 1976; 70(3):206-12. PubMed ID: 982514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A programme of multiple-antigen childhood immunization in Yaoundé, Cameroon: first-year evaluation, 1975-1976.
    Guyer B; Atangana S
    Bull World Health Organ; 1977; 55(5):633-42. PubMed ID: 303961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles control in Yaounde: justification of a one dose, nine month minimum age vaccination policy in tropical Africa.
    Heymann DL; Mayben GK; Murphy KR; Guyer B; Foster SO
    Lancet; 1983 Dec 24-31; 2(8365-66):1470-2. PubMed ID: 6140558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A general measles vaccination campaign in urban Guinea-Bissau: Comparing child mortality among participants and non-participants.
    Byberg S; Thysen SM; Rodrigues A; Martins C; Cabral C; Careme M; Aaby P; Benn CS; Fisker AB
    Vaccine; 2017 Jan; 35(1):33-39. PubMed ID: 27890397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of low measles vaccination coverage in children living in an endemic area.
    Lo Vecchio A; Cambriglia MD; Fedele MC; Basile FW; Chiatto F; Miraglia Del Giudice M; Guarino A
    Eur J Pediatr; 2019 Feb; 178(2):243-251. PubMed ID: 30430239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a measles outbreak response immunization campaign: Maroua, Cameroon, 2009.
    Goodson JL; Sosler S; Pasi O; Johnson T; Kobella M; Monono ME; Uzicanin A
    J Infect Dis; 2011 Jul; 204 Suppl 1():S252-9. PubMed ID: 21666170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and control of measles in Yaoundé, Cameroun, 1968-1975.
    Guyer B; McBean AM
    Int J Epidemiol; 1981 Sep; 10(3):263-9. PubMed ID: 7287287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
    J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age for measles immunization seroconversion after measles vaccination at 6-8 months of age--a randomized controlled trial.
    Deivanayagam N; Ramamurthy N; Krishnamurthy PV; Shankar VJ; Ashok TP; Nedunchelian K; Mala N; Ahmed SS
    Indian Pediatr; 1990 Nov; 27(11):1171-6. PubMed ID: 2081639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of immunization on measles incidence in the Democratic Republic of Congo: Results from a model of surveillance data.
    Doshi RH; Shidi C; Mulumba A; Eckhoff P; Nguyen C; Hoff NA; Gerber S; Okitolonda E; Ilunga BK; Rimoin AW
    Vaccine; 2015 Nov; 33(48):6786-92. PubMed ID: 26476363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expanded programme on immunization (EPI). Safety of high titre measles vaccines.
    Wkly Epidemiol Rec; 1992 Nov; 67(48):357-61. PubMed ID: 1449986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative routes of measles immunization: a review.
    Cutts FT; Clements CJ; Bennett JV
    Biologicals; 1997 Sep; 25(3):323-38. PubMed ID: 9325001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles susceptibility in children in Karachi, Pakistan.
    Sheikh S; Ali A; Zaidi AK; Agha A; Khowaja A; Allana S; Qureshi S; Azam I
    Vaccine; 2011 Apr; 29(18):3419-23. PubMed ID: 21396902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the mass measles vaccination campaign in Guangdong Province, China.
    Peng ZQ; Chen WS; He Q; Peng GW; Wu CG; Xu N; Zhao ZJ; Shu J; Tan Q; Zheng HZ; Lin LF; Deng HH; Lin JY; Zhang YH
    Int J Infect Dis; 2012 Feb; 16(2):e99-103. PubMed ID: 22119269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to measles immunization in rural Ghanaian infants.
    Sakatoku H; Nakano T; Arai S; Afari EA
    J Trop Pediatr; 1994 Oct; 40(5):291-3. PubMed ID: 7807624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.